ID SLIT1_MOUSE Reviewed; 1531 AA. AC Q80TR4; Q9WVB5; DT 15-MAR-2004, integrated into UniProtKB/Swiss-Prot. DT 15-MAR-2004, sequence version 2. DT 27-MAR-2024, entry version 184. DE RecName: Full=Slit homolog 1 protein; DE Short=Slit-1; DE Flags: Precursor; GN Name=Slit1; Synonyms=Kiaa0813; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH ROBO1, AND DEVELOPMENTAL RP STAGE. RC STRAIN=ICR X Swiss Webster; RX PubMed=10433822; DOI=10.1006/dbio.1999.9371; RA Yuan W., Zhou L., Chen J.H., Wu J.Y., Rao Y., Ornitz D.M.; RT "The mouse SLIT family: secreted ligands for ROBO expressed in patterns RT that suggest a role in morphogenesis and axon guidance."; RL Dev. Biol. 212:290-306(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=12693553; DOI=10.1093/dnares/10.1.35; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S., RA Nakajima D., Nagase T., Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: II. RT The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs RT identified by screening of terminal sequences of cDNA clones randomly RT sampled from size-fractionated libraries."; RL DNA Res. 10:35-48(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=C57BL/6J; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, AND DISRUPTION PHENOTYPE. RX PubMed=12097499; DOI=10.1523/jneurosci.22-13-05473.2002; RA Nguyen-Ba-Charvet K.T., Plump A.S., Tessier-Lavigne M., Chedotal A.; RT "Slit1 and slit2 proteins control the development of the lateral olfactory RT tract."; RL J. Neurosci. 22:5473-5480(2002). RN [5] RP FUNCTION. RX PubMed=11804571; DOI=10.1016/s0896-6273(02)00561-5; RA Bagri A., Marin O., Plump A.S., Mak J., Pleasure S.J., Rubenstein J.L., RA Tessier-Lavigne M.; RT "Slit proteins prevent midline crossing and determine the dorsoventral RT position of major axonal pathways in the mammalian forebrain."; RL Neuron 33:233-248(2002). RN [6] RP DEVELOPMENTAL STAGE. RX PubMed=10864955; DOI=10.1523/jneurosci.20-13-04975.2000; RA Erskine L., Williams S.E., Brose K., Kidd T., Rachel R.A., Goodman C.S., RA Tessier-Lavigne M., Mason C.A.; RT "Retinal ganglion cell axon guidance in the mouse optic chiasm: expression RT and function of robos and slits."; RL J. Neurosci. 20:4975-4982(2000). CC -!- FUNCTION: Thought to act as molecular guidance cue in cellular CC migration, and function appears to be mediated by interaction with CC roundabout homolog receptors. During neural development involved in CC axonal navigation at the ventral midline of the neural tube and CC projection of axons to different regions (By similarity). SLIT1 and CC SLIT2 together seem to be essential for midline guidance in the CC forebrain by acting as repulsive signal preventing inappropriate CC midline crossing by axons projecting from the olfactory bulb. CC {ECO:0000250, ECO:0000269|PubMed:11804571, CC ECO:0000269|PubMed:12097499}. CC -!- SUBUNIT: Interacts with GREM1 (By similarity) and ROBO1. {ECO:0000250, CC ECO:0000269|PubMed:10433822}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250}. CC -!- DEVELOPMENTAL STAGE: During retinal development, is expressed at 12.5 CC dpc in the dorsocentral region of the retina, and at 17.5 dpc is only CC very weakly expressed. In the developing optic chiasm is expressed at CC 12.5 dpc around the junction of the optic nerve and the brain, with CC strongest expression dorsal to the site at which the optic stalk joins CC the diencephalon, and also weakly in a subset of the CD44/SSEA neurons. CC In the more dorsal region of the developing optic chiasm, is expressed CC in some distance posterior to the axons. However, more ventrally, is CC expressed in a region directly adjacent to the path taken by the RGC CC axons. By 17.5 dpc is not longer be detected at the junction of the CC brain and optic nerve and is only weakly expressed by the CD44/SSEA CC neurons. Outside the developing brain detected at between 8.5 dpc and CC 9.5 dpc in the primordiun of the branchial arches, between 9.5 dpc and CC 10.5 dpc in the posterior dermamyotome. By 11.5 dpc the expression CC pattern along somite boundaries was most prominent caudally. Weak CC expression was also observed in the nasal pit at 11.5 dpc. From 13.5 CC dpc to 17.5 dpc expression was observed in the trigeminal ganglion, in CC the olfactory epithelium, and in the neural layer of the retina in the CC developing eye (with strongest expression in the inner nuclear layer). CC {ECO:0000269|PubMed:10433822, ECO:0000269|PubMed:10864955}. CC -!- DISRUPTION PHENOTYPE: Mice show significant axon guidance errors in a CC variety of pathways, including corticofugal, callosal and CC thalamocortical tracts. Mice double-deficient in SLIT1 and SLIT2 show CC retinal axon guidance defects and a disorganized lateral olfactory CC tract (LOT). {ECO:0000269|PubMed:12097499}. CC -!- SEQUENCE CAUTION: CC Sequence=BAC65658.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF144627; AAD44758.1; -; mRNA. DR EMBL; AK122376; BAC65658.1; ALT_INIT; mRNA. DR EMBL; BC057131; AAH57131.1; -; mRNA. DR EMBL; BC062091; AAH62091.1; -; mRNA. DR CCDS; CCDS29812.1; -. DR RefSeq; NP_056563.2; NM_015748.3. DR RefSeq; XP_011245502.1; XM_011247200.2. DR AlphaFoldDB; Q80TR4; -. DR BioGRID; 203327; 3. DR IntAct; Q80TR4; 1. DR MINT; Q80TR4; -. DR STRING; 10090.ENSMUSP00000025993; -. DR GlyCosmos; Q80TR4; 13 sites, No reported glycans. DR GlyGen; Q80TR4; 13 sites. DR iPTMnet; Q80TR4; -. DR PhosphoSitePlus; Q80TR4; -. DR MaxQB; Q80TR4; -. DR PaxDb; 10090-ENSMUSP00000025993; -. DR ProteomicsDB; 257198; -. DR Antibodypedia; 1515; 221 antibodies from 27 providers. DR DNASU; 20562; -. DR Ensembl; ENSMUST00000025993.10; ENSMUSP00000025993.4; ENSMUSG00000025020.12. DR GeneID; 20562; -. DR KEGG; mmu:20562; -. DR UCSC; uc008hmf.2; mouse. DR AGR; MGI:1315203; -. DR CTD; 6585; -. DR MGI; MGI:1315203; Slit1. DR VEuPathDB; HostDB:ENSMUSG00000025020; -. DR eggNOG; KOG4237; Eukaryota. DR GeneTree; ENSGT00940000157322; -. DR InParanoid; Q80TR4; -. DR OMA; ETKCQNN; -. DR OrthoDB; 5475408at2759; -. DR PhylomeDB; Q80TR4; -. DR TreeFam; TF332887; -. DR BioGRID-ORCS; 20562; 0 hits in 78 CRISPR screens. DR ChiTaRS; Slit1; mouse. DR PRO; PR:Q80TR4; -. DR Proteomes; UP000000589; Chromosome 19. DR RNAct; Q80TR4; Protein. DR Bgee; ENSMUSG00000025020; Expressed in dentate gyrus of hippocampal formation granule cell and 89 other cell types or tissues. DR ExpressionAtlas; Q80TR4; baseline and differential. DR GO; GO:0005615; C:extracellular space; IDA:MGI. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro. DR GO; GO:0043395; F:heparan sulfate proteoglycan binding; ISO:MGI. DR GO; GO:0008201; F:heparin binding; IBA:GO_Central. DR GO; GO:0048495; F:Roundabout binding; IPI:MGI. DR GO; GO:0005102; F:signaling receptor binding; TAS:MGI. DR GO; GO:0048846; P:axon extension involved in axon guidance; ISO:MGI. DR GO; GO:0007411; P:axon guidance; IDA:MGI. DR GO; GO:0007409; P:axonogenesis; IDA:MGI. DR GO; GO:0033563; P:dorsal/ventral axon guidance; IGI:MGI. DR GO; GO:0008045; P:motor neuron axon guidance; ISO:MGI. DR GO; GO:0050919; P:negative chemotaxis; IMP:MGI. DR GO; GO:0048843; P:negative regulation of axon extension involved in axon guidance; ISO:MGI. DR GO; GO:0051964; P:negative regulation of synapse assembly; ISS:UniProtKB. DR GO; GO:0048812; P:neuron projection morphogenesis; IGI:MGI. DR GO; GO:0007097; P:nuclear migration; IDA:MGI. DR GO; GO:0021772; P:olfactory bulb development; IGI:MGI. DR GO; GO:0031290; P:retinal ganglion cell axon guidance; IMP:MGI. DR GO; GO:0021510; P:spinal cord development; IEA:Ensembl. DR GO; GO:0022028; P:tangential migration from the subventricular zone to the olfactory bulb; IMP:MGI. DR GO; GO:0022029; P:telencephalon cell migration; IGI:MGI. DR CDD; cd00054; EGF_CA; 6. DR CDD; cd00110; LamG; 1. DR Gene3D; 2.60.120.200; -; 1. DR Gene3D; 2.10.25.10; Laminin; 8. DR Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 5. DR InterPro; IPR013320; ConA-like_dom_sf. DR InterPro; IPR000483; Cys-rich_flank_reg_C. DR InterPro; IPR006207; Cys_knot_C. DR InterPro; IPR001881; EGF-like_Ca-bd_dom. DR InterPro; IPR013032; EGF-like_CS. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site. DR InterPro; IPR018097; EGF_Ca-bd_CS. DR InterPro; IPR003645; Fol_N. DR InterPro; IPR001791; Laminin_G. DR InterPro; IPR001611; Leu-rich_rpt. DR InterPro; IPR003591; Leu-rich_rpt_typical-subtyp. DR InterPro; IPR032675; LRR_dom_sf. DR InterPro; IPR000372; LRRNT. DR PANTHER; PTHR45836:SF23; LRRCT DOMAIN-CONTAINING PROTEIN; 1. DR PANTHER; PTHR45836; SLIT HOMOLOG; 1. DR Pfam; PF00008; EGF; 4. DR Pfam; PF12661; hEGF; 2. DR Pfam; PF02210; Laminin_G_2; 1. DR Pfam; PF13855; LRR_8; 6. DR Pfam; PF01463; LRRCT; 4. DR Pfam; PF01462; LRRNT; 4. DR SMART; SM00041; CT; 1. DR SMART; SM00181; EGF; 9. DR SMART; SM00179; EGF_CA; 7. DR SMART; SM00274; FOLN; 3. DR SMART; SM00282; LamG; 1. DR SMART; SM00364; LRR_BAC; 6. DR SMART; SM00365; LRR_SD22; 8. DR SMART; SM00369; LRR_TYP; 18. DR SMART; SM00082; LRRCT; 4. DR SMART; SM00013; LRRNT; 4. DR SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1. DR SUPFAM; SSF57196; EGF/Laminin; 5. DR SUPFAM; SSF52058; L domain-like; 2. DR PROSITE; PS01185; CTCK_1; 1. DR PROSITE; PS01225; CTCK_2; 1. DR PROSITE; PS00022; EGF_1; 9. DR PROSITE; PS01186; EGF_2; 8. DR PROSITE; PS50026; EGF_3; 9. DR PROSITE; PS01187; EGF_CA; 2. DR PROSITE; PS50025; LAM_G_DOMAIN; 1. DR PROSITE; PS51450; LRR; 21. DR Genevisible; Q80TR4; MM. PE 1: Evidence at protein level; KW Developmental protein; Differentiation; Disulfide bond; EGF-like domain; KW Glycoprotein; Leucine-rich repeat; Neurogenesis; Reference proteome; KW Repeat; Secreted; Signal. FT SIGNAL 1..33 FT /evidence="ECO:0000255" FT CHAIN 34..1531 FT /note="Slit homolog 1 protein" FT /id="PRO_0000007723" FT DOMAIN 34..61 FT /note="LRRNT" FT REPEAT 62..83 FT /note="LRR 1" FT REPEAT 86..107 FT /note="LRR 2" FT REPEAT 110..131 FT /note="LRR 3" FT REPEAT 134..155 FT /note="LRR 4" FT REPEAT 158..179 FT /note="LRR 5" FT REPEAT 182..203 FT /note="LRR 6" FT DOMAIN 215..265 FT /note="LRRCT 1" FT DOMAIN 273..309 FT /note="LRRNT 23" FT REPEAT 310..331 FT /note="LRR 7" FT REPEAT 334..355 FT /note="LRR 8" FT REPEAT 358..379 FT /note="LRR 9" FT REPEAT 382..403 FT /note="LRR 10" FT REPEAT 406..427 FT /note="LRR 11" FT DOMAIN 439..489 FT /note="LRRCT 2" FT DOMAIN 504..540 FT /note="LRRNT 3" FT REPEAT 541..562 FT /note="LRR 12" FT REPEAT 566..587 FT /note="LRR 13" FT REPEAT 590..611 FT /note="LRR 14" FT REPEAT 614..635 FT /note="LRR 15" FT REPEAT 638..659 FT /note="LRR 16" FT DOMAIN 671..721 FT /note="LRRCT 3" FT DOMAIN 725..761 FT /note="LRRNT 4" FT REPEAT 762..783 FT /note="LRR 17" FT REPEAT 785..806 FT /note="LRR 18" FT REPEAT 809..830 FT /note="LRR 19" FT REPEAT 833..854 FT /note="LRR 20" FT DOMAIN 866..916 FT /note="LRRCT 4" FT DOMAIN 927..962 FT /note="EGF-like 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 964..1003 FT /note="EGF-like 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1005..1041 FT /note="EGF-like 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1043..1081 FT /note="EGF-like 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1083..1119 FT /note="EGF-like 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1124..1160 FT /note="EGF-like 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1163..1336 FT /note="Laminin G-like" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00122" FT DOMAIN 1337..1371 FT /note="EGF-like 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1374..1410 FT /note="EGF-like 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1415..1451 FT /note="EGF-like 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00076" FT DOMAIN 1456..1531 FT /note="CTCK" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00039" FT CARBOHYD 72 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 192 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 406 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 571 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 630 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 762 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 801 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 806 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1026 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1079 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1186 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1256 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 1303 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 286..295 FT /evidence="ECO:0000250" FT DISULFID 443..466 FT /evidence="ECO:0000250" FT DISULFID 445..487 FT /evidence="ECO:0000250" FT DISULFID 513..519 FT /evidence="ECO:0000250" FT DISULFID 517..526 FT /evidence="ECO:0000250" FT DISULFID 675..698 FT /evidence="ECO:0000250" FT DISULFID 677..719 FT /evidence="ECO:0000250" FT DISULFID 929..940 FT /evidence="ECO:0000250" FT DISULFID 934..950 FT /evidence="ECO:0000250" FT DISULFID 952..961 FT /evidence="ECO:0000250" FT DISULFID 968..979 FT /evidence="ECO:0000250" FT DISULFID 973..991 FT /evidence="ECO:0000250" FT DISULFID 993..1002 FT /evidence="ECO:0000250" FT DISULFID 1009..1020 FT /evidence="ECO:0000250" FT DISULFID 1014..1029 FT /evidence="ECO:0000250" FT DISULFID 1031..1040 FT /evidence="ECO:0000250" FT DISULFID 1047..1060 FT /evidence="ECO:0000250" FT DISULFID 1054..1069 FT /evidence="ECO:0000250" FT DISULFID 1071..1080 FT /evidence="ECO:0000250" FT DISULFID 1087..1098 FT /evidence="ECO:0000250" FT DISULFID 1092..1107 FT /evidence="ECO:0000250" FT DISULFID 1109..1118 FT /evidence="ECO:0000250" FT DISULFID 1128..1139 FT /evidence="ECO:0000250" FT DISULFID 1133..1148 FT /evidence="ECO:0000250" FT DISULFID 1150..1159 FT /evidence="ECO:0000250" FT DISULFID 1310..1336 FT /evidence="ECO:0000250" FT DISULFID 1339..1349 FT /evidence="ECO:0000250" FT DISULFID 1344..1359 FT /evidence="ECO:0000250" FT DISULFID 1361..1370 FT /evidence="ECO:0000250" FT DISULFID 1378..1388 FT /evidence="ECO:0000250" FT DISULFID 1383..1398 FT /evidence="ECO:0000250" FT DISULFID 1400..1409 FT /evidence="ECO:0000250" FT DISULFID 1419..1429 FT /evidence="ECO:0000250" FT DISULFID 1424..1439 FT /evidence="ECO:0000250" FT DISULFID 1441..1450 FT /evidence="ECO:0000250" FT DISULFID 1456..1495 FT /evidence="ECO:0000250" FT DISULFID 1474..1509 FT /evidence="ECO:0000250" FT DISULFID 1485..1525 FT /evidence="ECO:0000250" FT DISULFID 1489..1527 FT /evidence="ECO:0000250" FT CONFLICT 44 FT /note="Missing (in Ref. 3; AAH57131/AAH62091)" FT /evidence="ECO:0000305" FT CONFLICT 830 FT /note="G -> R (in Ref. 1; AAD44758)" FT /evidence="ECO:0000305" FT CONFLICT 1531 FT /note="A -> V (in Ref. 1; AAD44758 and 2; BAC65658)" FT /evidence="ECO:0000305" SQ SEQUENCE 1531 AA; 167420 MW; C0F1C5A4E3DF6108 CRC64; MALTPQRGSS SGLSRPELWL LLWAAAWRLG ATACPALCTC TGTTVDCHGT GLQAIPKNIP RNTERLELNG NNITRIHKND FAGLKQLRVL QLMENQIGAV ERGAFDDMKE LERLRLNRNQ LQVLPELLFQ NNQALSRLDL SENFLQAVPR KAFRGATDLK NLQLDKNRIS CIEEGAFRAL RGLEVLTLNN NNITTIPVSS FNHMPKLRTF RLHSNHLFCD CHLAWLSQWL RQRPTIGLFT QCSGPASLRG LNVAEVQKGE FSCSGQGEAA GAPACTLSSG SCPAMCSCSS GIVDCRGKGL TAIPANLPET MTEIRLELNG IKSIPPGAFS PYRKLRRIDL SNNQIAEIAP DAFQGLRSLN SLVLYGNKIT DLPRGVFGGL YTLQLLLLNA NKINCIRPDA FQDLQNLSLL SLYDNKIQSL AKGTFTSLRA IQTLHLAQNP FICDCNLKWL ADFLRTNPIE TTGARCASPR RLANKRIGQI KSKKFRCSAK EQYFIPGTED YHLNSECTSD VACPHKCRCE ASVVECSSLK LSKIPERIPQ STTELRLNNN EISILEATGL FKKLSHLKKI NLSNNKVSEI EDGTFEGAAS VSELHLTANQ LESIRSGMFR GLDGLRTLML RNNRISCIHN DSFTGLRNVR LLSLYDNHIT TISPGAFDTL QALSTLNLLA NPFNCNCHLS WLGDWLRKRK IVTGNPRCQN PDFLRQIPLQ DVAFPDFRCE EGQEEVGCLP RPQCPQECAC LDTVVRCSNK HLQALPKGIP KNVTELYLDG NQFTLVPGQL STFKYLQLVD LSNNKISSLS NSSFTNMSQL TTLILSYNAL QCIPPLAFQG LRSLRLLSLH GNDVSTLQEG IFADVTSLSH LAIGANPLYC DCRLRWLSSW VKTGYKEPGI ARCAGPPEME GKLLLTTPAK KFECQGPPSL AVQAKCDPCL SSPCQNQGTC HNDPLEVYRC TCPSGYKGRH CEVSLDGCSS NPCGNGGTCH AQEGEDAGFT CSCPSGFEGP TCGVDTDDCV KHACVNGGVC VDGVGNYTCQ CPLQYTGRAC EQLVDFCSPD MNPCQHEAQC VGTPDGPRCE CMLGYTGDNC SENQDDCKDH KCQNGAQCVD EVNSYACLCV EGYSGQLCEI PPAPRSSCEG TECQNGANCV DQGSRPVCQC LPGFGGPECE KLLSVNFVDR DTYLQFTDLQ NWPRANITLQ VSTAEDNGIL LYNGDNDHIA VELYQGHVRV SYDPGSYPSS AIYSAETIND GQFHTVELVT FDQMVNLSID GGSPMTMDNF GKHYTLNSEA PLYVGGMPVD VNSAAFRLWQ ILNGTSFHGC IRNLYINNEL QDFTKTQMKP GVVPGCEPCR KLYCLHGICQ PNATPGPVCH CEAGWGGLHC DQPVDGPCHG HKCVHGKCVP LDALAYSCQC QDGYSGALCN QVGAVAEPCG GLQCLHGHCQ ASATKGAHCV CSPGFSGELC EQESECRGDP VRDFHRVQRG YAICQTTRPL SWVECRGACP GQGCCQGLRL KRRKLTFECS DGTSFAEEVE KPTKCGCAQC A //